Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer

Javad Biabani Ardakani & Seyed Jalal Hosseinimehr et al. · 2020-11-13

Human epidermal growth factor receptor 2 (HER2) overexpression, as a predictive biomarker, is associated with more tumor aggressiveness and worse clinical outcomes in cancer, whereas it's accurate identification has led to the choice of effective treatments in many patients. In this study, a peptide-based PET probe (
Authors
Javad Biabani Ardakani, Mehdi Akhlaghi, Babak Nikkholgh, Seyed Jalal Hosseinimehr